5Ksimmons WD,Rayhill SC,Sollinger HW.Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection[J].Drug Saf,1997,17(2):75-92.
6Lu DP,Dong L,Wu T,et al.Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation[J].Blood,2006,107(8):3065-3073.
7Russell JA,Turner AR,Larratt L,et al.Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease:a matched pair analysis[J].Biol Blood Marrow Transplant,2007,13(3):299-306.
8Xu H,Chilton PM,Huang Y,et al.Addition of cyclophosphamide to T-cell depletion-based Nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cell after bone marrow transplantation[J].Transplantation,2007,83(7):954-963.
2Ringd6n O,Remberger M,Holmberg K,et al. Many Days at Home during Neutropenia after Allogeneic Hematopoietic Stem Cell Transplantation Correlates with Low Incidence of Acute Graft-versus-Host Disease[J]. Biology of Blood and Marrow Transplantation, 2013,19(2) :314-320.
3Wulff-Burchfield EM,Savani BN. Building a transplanta- tion physician workforce for growing need:Recruitment starts during residency[J]. Biology of Blood and Marrow Transplantation, 2013,19(8) : 1142-1143.
5Tanzi EM. Health-related quality of life of hematopoietic stem cell transplant childhood survivors:State of the sci- ence[J]. Journal of Pediatric Oncology Nursing, 2011,28 (4) : 191-202.
